BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32461544)

  • 1. Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up.
    Paillassa J; Cornet E; Noel S; Tomowiak C; Lepretre S; Vaudaux S; Dupuis J; Devidas A; Joly B; Petitdidier-Lionnet C; Haiat S; Mariette C; Thieblemont C; Decaudin D; Validire-Charpy P; Drenou B; Eisenmann JC; Uribe MO; Olivrie A; Touati M; Lambotte O; Hermine O; Karsenti JM; Feugier P; Vaillant W; Gutnecht J; Lippert E; Huysman F; Ghomari K; Boubaya M; Levy V; Riou J; Damaj G; Tanguy-Schmidt A; Hunault-Berger M; Troussard X
    Blood Cancer J; 2020 May; 10(5):62. PubMed ID: 32461544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.
    Madanat YF; Rybicki L; Radivoyevitch T; Jagadeesh D; Dean R; Pohlman B; Kalaycio M; Sekeres MA; Smith MR; Hill BT
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):857-862. PubMed ID: 28778620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
    Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
    Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.
    Dearden CE; Matutes E; Hilditch BL; Swansbury GJ; Catovsky D
    Br J Haematol; 1999 Aug; 106(2):515-9. PubMed ID: 10460614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.
    Goodman GR; Burian C; Koziol JA; Saven A
    J Clin Oncol; 2003 Mar; 21(5):891-6. PubMed ID: 12610190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results for pentostatin and cladribine treatment of hairy cell leukemia.
    Dearden CE; Else M; Catovsky D
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():21-4. PubMed ID: 21599603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignancies in patients with hairy cell leukemia in british columbia: a 20-year experience.
    Au WY; Klasa RJ; Gallagher R; Le N; Gascoyne RD; Connors JM
    Blood; 1998 Aug; 92(4):1160-4. PubMed ID: 9694703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
    Else M; Dearden CE; Matutes E; Forconi F; Lauria F; Ahmad H; Kelly S; Liyanage A; Ratnayake V; Shankari J; Whalley I; Catovsky D
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():75-8. PubMed ID: 21504288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
    Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
    Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of patients with hairy cell leukemia in the south of Iran.
    Dehghani M; Kashkooe A; Namdari N; Majidi R; Karimi M; Haghighat S; Rezvani A; Safari N
    Expert Rev Hematol; 2023 Apr; 16(4):289-295. PubMed ID: 36709461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. My treatment approach to hairy cell leukemia.
    Naik RR; Saven A
    Mayo Clin Proc; 2012 Jan; 87(1):67-76. PubMed ID: 22212971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
    Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB
    Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment.
    Saven A; Burian C; Koziol JA; Piro LD
    Blood; 1998 Sep; 92(6):1918-26. PubMed ID: 9731048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
    Else M; Dearden CE; Catovsky D
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second cancer risk in hairy cell leukemia: analysis of 350 patients.
    Kurzrock R; Strom SS; Estey E; O'Brien S; Keating MJ; Jiang H; Adams T; Talpaz M
    J Clin Oncol; 1997 May; 15(5):1803-10. PubMed ID: 9164188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia.
    Cornet E; Tomowiak C; Tanguy-Schmidt A; Lepretre S; Dupuis J; Feugier P; Devidas A; Mariette C; Leblond V; Thiéblemont C; Validire-Charpy P; Sutton L; Gyan E; Eisenmann JC; Cony-Makhoul P; Ysebaert L; Troussard X;
    Br J Haematol; 2014 Aug; 166(3):390-400. PubMed ID: 24749839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.
    Else M; Dearden CE; Matutes E; Garcia-Talavera J; Rohatiner AZ; Johnson SA; O'Connor NT; Haynes A; Osuji N; Forconi F; Lauria F; Catovsky D
    Br J Haematol; 2009 Jun; 145(6):733-40. PubMed ID: 19344416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
    Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
    Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.